Tine et al., 1993 - Google Patents
Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virusTine et al., 1993
View PDF- Document ID
- 13976502434060780338
- Author
- Tine J
- Conseil V
- Delplace P
- De Taisne C
- Camus D
- Paoletti E
- Publication year
- Publication venue
- Infection and immunity
External Links
Snippet
cDNA encoding the serine repeat antigen (SERA)(also called p126) of Plasmodium falciparum has been isolated from the FCR3 strain and inserted into a recombinant vaccinia virus designated vP870. Expression analysis of vP870-infected Vero cells by …
- 241000700618 Vaccinia virus 0 title abstract description 28
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5766597A (en) | Malaria recombinant poxviruses | |
Marshall et al. | A second merozoite surface protein (MSP-4) of Plasmodium falciparum that contains an epidermal growth factor-like domain | |
Scherf et al. | Gene inactivation of Pf11‐1 of Plasmodium falciparum by chromosome breakage and healing: identification of a gametocyte‐specific protein with a potential role in gametogenesis. | |
Blisnick et al. | Pfsbp1, a Maurer's cleft Plasmodium falciparum protein, is associated with the erythrocyte skeleton | |
Fidock et al. | Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. | |
US5814617A (en) | Protective 17 KDA malaria hepatic and erythrocytic stage immunogen and gene | |
Holder et al. | Serological cross-reaction between high molecular weight proteins synthesized in blood schizonts of Plasmodium yoelii, Plasmodium chabaudi and Plasmodium falciparum | |
Jenkins et al. | cDNA encoding an immunogenic region of a 22 kilodalton surface protein of Eimeria acervulina sporozoites | |
EP0390267B1 (en) | Coccidiosis vaccine | |
Gardner et al. | DNA vaccines against malaria: immunogenicity and protection in a rodent model | |
Binger et al. | Cloning and characterization of a surface antigen of Eimeria tenella merozoites and expression using a recombinant vaccinia virus | |
Daugherty et al. | Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies | |
AU709479B2 (en) | Recombinant attentuated canrypox ALVAC virus expression vectors containing heterologous DNA segments encoding malarial gene products | |
US4978621A (en) | Merozoite surface antigens | |
Mishra et al. | Immunogenicity and sequence analysis of recombinant p58: a neutralization-sensitive, antigenically conserved Babesia bigemina merozoite surface protein | |
Tine et al. | Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus | |
Bohne et al. | Bradyzoite-specific genes | |
US5116755A (en) | Asexual blood stage antigens of plasmodium falciparum which encode a rhoptry protein | |
Fandeur et al. | Protection of squirrel monkeys against virulent Plasmodium falciparum infections by use of attenuated parasites | |
AU661982B2 (en) | Cloning and expression of a protein antigen of toxoplasma gondii | |
US5393523A (en) | Plasmodium falciparum vaccine comprising a recombinant histidine-rich protein-HRP-II | |
EP0372019B1 (en) | RHOPTRY MEMBRANE ANTIGEN OF $i(PLASMODIUM FALCIPARUM) | |
Yang et al. | Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus | |
Wang et al. | Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein | |
Moelans | Pfs16, a potential vaccine candidate against the human malaria parasite Plasmodium falciparum |